Global disparities in SARS-CoV-2 genomic surveillance

[1]  Michael J. Ryan,et al.  Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022–2032 , 2022, Bulletin of the World Health Organization.

[2]  M. Pai,et al.  It is not too late to achieve global covid-19 vaccine equity , 2022, BMJ.

[3]  Arun G. Chandrasekhar,et al.  End COVID-19 in low- and middle-income countries , 2022, Science.

[4]  Bruce G. Link,et al.  The radically unequal distribution of Covid-19 vaccinations: a predictable yet avoidable symptom of the fundamental causes of inequality , 2022, Humanities and Social Sciences Communications.

[5]  Yang Ye,et al.  Equitable access to COVID-19 vaccines makes a life-saving difference to all countries , 2022, Nature Human Behaviour.

[6]  M. Kraemer,et al.  Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa , 2021, Nature.

[7]  M. V. Van Kerkhove,et al.  Preparing for “Disease X” , 2021, Science.

[8]  L. du Plessis,et al.  Genomic Epidemiology of Early SARS-CoV-2 Transmission Dynamics, Gujarat, India , 2021, medRxiv.

[9]  G. Saberwal,et al.  The lag in SARS-CoV-2 genome submissions to GISAID , 2021, Nature Biotechnology.

[10]  A. F. Bochner,et al.  7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics , 2021, The Lancet.

[11]  N. Loman,et al.  CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance , 2021, Genome Biology.

[12]  N. Loman,et al.  CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance , 2021, Genome biology.

[13]  J. Sharfstein,et al.  Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity. , 2021, The New England journal of medicine.

[14]  L. Christiansen,et al.  Introduction and transmission of SARS-CoV-2 B.1.1.7 in Denmark , 2021, medRxiv.

[15]  William T. Harvey,et al.  SARS-CoV-2 variants, spike mutations and immune escape , 2021, Nature Reviews Microbiology.

[16]  G. Wallau,et al.  COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence , 2021, Nature Medicine.

[17]  M. Wadman.  Blind spots thwart global coronavirus tracking. , 2021, Science.

[18]  H. Ling,et al.  Emerging Variants of B.1.617 Lineage Identified Among Returning Chinese Employees Working in India — Chongqing Municipality, China, April 2021 , 2021, China CDC weekly.

[19]  A. Maxmen.  Why some researchers oppose unrestricted sharing of coronavirus genome data , 2021, Nature.

[20]  A. Maxmen.  One million coronavirus sequences: popular genome site hits mega milestone , 2021, Nature.

[21]  M. Suchard,et al.  Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil , 2021, Science.

[22]  A. Huppert,et al.  Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals , 2021, Nature Medicine.

[23]  A. Maxmen.  Why US coronavirus tracking can’t keep up with concerning variants , 2021, Nature.

[24]  Toshiro Sato,et al.  COVID-19 reinfection: a rapid systematic review of case reports and case series , 2021, Journal of Investigative Medicine.

[25]  Graham W. Taylor,et al.  Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Nature.

[26]  Sergei L. Kosakovsky Pond,et al.  Detection of a SARS-CoV-2 variant of concern in South Africa , 2021, Nature.

[27]  T. Lancet.  Genomic sequencing in pandemics , 2021, The Lancet.

[28]  J. Nkengasong,et al.  Genomic-informed pathogen surveillance in Africa: opportunities and challenges , 2021, The Lancet Infectious Diseases.

[29]  E. Hodcroft,et al.  Public health actions to control new SARS-CoV-2 variants , 2021, Cell.

[30]  D. Cyranoski.  Alarming COVID variants show vital role of genomic surveillance , 2021, Nature.

[31]  P. Febbo,et al.  Genomic surveillance at scale is required to detect newly emerging strains at an early timepoint , 2021 .

[32]  E. Hodcroft,et al.  Genetic Variants of SARS-CoV-2-What Do They Mean? , 2021, JAMA.

[33]  K. V. Parag,et al.  Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK , 2020, medRxiv.

[34]  A. R. Sequeira,et al.  Responses to COVID-19 in five Latin American countries , 2020, Health Policy and Technology.

[35]  F. Giardina,et al.  Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy , 2020, Nature Communications.

[36]  Richard Molenkamp,et al.  Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands , 2020, Nature Medicine.

[37]  Y. Adebisi,et al.  SARS-CoV-2 diagnostic testing in Africa: needs and challenges , 2020, The Pan African medical journal.

[38]  P. Lemey,et al.  Tracking virus outbreaks in the twenty-first century , 2018, Nature Microbiology.

[39]  Jennifer L. Gardy,et al.  Towards a genomics-informed, real-time, global pathogen surveillance system , 2017, Nature Reviews Genetics.

[40]  Yuelong Shu,et al.  GISAID: Global initiative on sharing all influenza data – from vision to reality , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[41]  Stefan Elbe,et al.  Data, disease and diplomacy: GISAID's innovative contribution to global health , 2017, Global challenges.

[42]  Yiming Bao,et al.  NCBI Viral Genomes Resource , 2014, Nucleic Acids Res..

[43]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[44]  A. Rodrigo,et al.  Measurably evolving populations , 2003 .

[45]  A. Parant.  [World population prospects]. , 1990, Futuribles.

[46]  Guidance for representative and targeted genomic SARS-CoV-2 monitoring , 2021 .

[47]  Emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA , 2021 .

[48]  Genomic sequencing of SARS-CoV-2 , 2021 .

[49]  Policy statement on data sharing by WHO in the context of public health emergencies (as of 13 April 2016. , 2016, Releve epidemiologique hebdomadaire.

[50]  A. Alavi,et al.  Opportunities and Challenges , 1998, In Vitro Diagnostic Industry in China.

[51]  E Howard,et al.  Needs and challenges , 1986 .

[52]  S. Armato,et al.  Semantics and image content integration for pulmonary nodule interpretation in thoracic computed tomography , 2007, SPIE Medical Imaging.

[53]  G. Domselaar,et al.  CanCOGeN Interim Recommendations for Naming, Identifying, and Reporting SARS-CoV-2 Variants of Concern , 2022 .